Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Annals of oncology

Results: 1-25/301

Authors: SPANJER M
Citation: M. Spanjer, DRUGS - HOLLAND BOWS TO INTERNATIONAL PRESSURE, Annals of oncology, 6(9), 1995, pp. 854-854

Citation: BREAST-CANCER - TO SCREEN OR NOT TO SCREEN, Annals of oncology, 6(9), 1995, pp. 855-856

Citation: IN THE UK-NATIONAL-LOTTERY HURTS CHARITIES AND OTHERS, Annals of oncology, 6(9), 1995, pp. 855-855

Citation: NO MORE TREATMENT FOR LOS-ANGELES IMPOVERISHED CANCER-PATIENTS, Annals of oncology, 6(9), 1995, pp. 856-857

Citation: TURBULENT TIMES FOR CANCER STRUCTURES IN THE US, Annals of oncology, 6(9), 1995, pp. 857-858

Citation: FDA - QUALITY-OF-LIFE MATTERS, Annals of oncology, 6(9), 1995, pp. 858-858

Citation: PERHAPS NOT EVERYONE KNOWS THAT, Annals of oncology, 6(9), 1995, pp. 859-860

Citation: THEORETICAL AND PRACTICAL ASPECTS OF PACLITAXEL SCHEDULING, Annals of oncology, 6(9), 1995, pp. 861-863

Citation: EARLY OVARIAN-CANCER - TREAT NOW, LATER OR NEVER, Annals of oncology, 6(9), 1995, pp. 865-866

Authors: BUCHANAN L LAIDLAW C POULTON G
Citation: L. Buchanan et al., THE ADEQUACY OF CONSENT FORMS FOR INFORMING PATIENTS ENTERING ONCOLOGICAL CLINICAL-TRIALS, Annals of oncology, 6(9), 1995, pp. 867-870

Authors: JACKMAN AL CALVERT AH
Citation: Al. Jackman et Ah. Calvert, FOLATE-BASED THYMIDYLATE SYNTHASE INHIBITORS AS ANTICANCER DRUGS, Annals of oncology, 6(9), 1995, pp. 871-881

Authors: LOKICH J ANDERSON N BERN M COCO F DOW E MOORE C ZIPOLI T GONZALVES L
Citation: J. Lokich et al., MULTI-DAY FRACTIONATED ADMINISTRATION SCHEDULE FOR PACLITAXEL, Annals of oncology, 6(9), 1995, pp. 883-885

Authors: BOLIS G COLOMBO N PECORELLI S TORRI V MARSONI S BONAZZI C CHIARI S FAVALLI G MANGILI C PRESTI M ZANABONI F MANGIONI C
Citation: G. Bolis et al., ADJUVANT TREATMENT FOR EARLY EPITHELIAL OVARIAN-CANCER - RESULTS OF 2RANDOMIZED CLINICAL-TRIALS COMPARING CISPLATIN TO NO FURTHER TREATMENT OR CHROMIC PHOSPHATE (P-32), Annals of oncology, 6(9), 1995, pp. 887-893

Authors: BJORKHOLM M AXDORPH U GRIMFORS G MERK K JOHANSSON B LANDGREN O SVEDMYR E MELLSTEDT H HOLM G
Citation: M. Bjorkholm et al., FIRED VERSUS RESPONSE-ADAPTED MOPP ABVD CHEMOTHERAPY IN HODGKINS-DISEASE - A PROSPECTIVE RANDOMIZED TRIAL/, Annals of oncology, 6(9), 1995, pp. 895-899

Authors: DIEHL V LOEFFLER M PFREUNDSCHUH M RUEHL U HASENCLEVER D NISTERSBACKES H SIEBER M SMITH K TESCH H GEILEN W ADLER M BARTELS H BRANDENBURG U DIEZLER P DOELKEN G ENZIAN J FUCHS R GASSMANN W GERHARTZ H HAGENAUKAMP U HECHT T HILLER E HINKELBEIN H LATHAN B KIRCHNER H KUEHN G KUERTEN H LOOS U MAKOSKI B OERTEL W PETSCH S PFAB R PFLUEGER H PLANKER M ROHLOFF R SACK H SAMANDARI S SAUER R SCHALK K SCHMITZ G SCHOPPE W SCHWIEDER G SZEPESI S TEICHMANN J WILHELMY W WORST P FISCHER R GEORGII A HUEBNER K SCHWARZE EW
Citation: V. Diehl et al., FURTHER CHEMOTHERAPY VERSUS LOW-DOSE INVOLVED-FIELD RADIOTHERAPY AS CONSOLIDATION OF COMPLETE REMISSION AFTER 6 CYCLES OF ALTERNATING CHEMOTHERAPY IN PATIENTS WITH ADVANCED HODGKINS-DISEASE, Annals of oncology, 6(9), 1995, pp. 901-910

Authors: AMATO R MEYERS C ELLERHORST J FINN L KILBOURN R SELLA A LOGOTHETIS C
Citation: R. Amato et al., A PHASE-I TRIAL OF INTERMITTENT HIGH-DOSE ALPHA-INTERFERON AND DEXAMETHASONE IN METASTATIC RENAL-CELL CARCINOMA, Annals of oncology, 6(9), 1995, pp. 911-914

Authors: MASSIMINO M GASPARINI M GIARDINI R
Citation: M. Massimino et al., KI-1 (CD30) ANAPLASTIC LARGE-CELL LYMPHOMA IN CHILDREN, Annals of oncology, 6(9), 1995, pp. 915-920

Authors: FISCHER JR SCHINDEL M STEIN N LAHM H GALLATI H KRAMMER PH DRINGS P
Citation: Jr. Fischer et al., SELECTIVE SUPPRESSION OF CYTOKINE SECRETION IN PATIENTS WITH SMALL-CELL LUNG-CANCER, Annals of oncology, 6(9), 1995, pp. 921-926

Authors: IZQUIERDO MA DEGEN D MYERS L LEVITT DJ VONHOFF DD
Citation: Ma. Izquierdo et al., EFFECTS OF THE HEMATOPOIETIC GROWTH-FACTORS GM-CSF, IL-3, AND IL-6 ONHUMAN TUMOR COLONY-FORMING-UNITS TAKEN DIRECTLY FROM PATIENTS, Annals of oncology, 6(9), 1995, pp. 927-932

Authors: GASPAROTTO D MAESTRO R BARZAN L VUKOSAVLJEVIC T DOGLIONI C SULFARO S PICCININ S BOIOCCHI M
Citation: D. Gasparotto et al., RECURRENCES AND 2ND PRIMARY TUMORS IN THE HEAD AND NECK REGION - DIFFERENTIATION BY P53 MUTATION ANALYSIS, Annals of oncology, 6(9), 1995, pp. 933-939

Authors: LASSEN U KRISTJANSEN PEG HANSEN HH
Citation: U. Lassen et al., BRAIN METASTASES IN SMALL-CELL LUNG-CANCER, Annals of oncology, 6(9), 1995, pp. 941-944

Authors: BOLETI E DEONARAIN MP SPOONER RA SMITH AJ EPENETOS AA GEORGE AJT
Citation: E. Boleti et al., CONSTRUCTION, EXPRESSION AND CHARACTERIZATION OF A SINGLE-CHAIN ANTITUMOR ANTIBODY (SCFV)-IL-2 FUSION PROTEIN, Annals of oncology, 6(9), 1995, pp. 945-947

Authors: SMYTH JE HARDCASTLE JD DENTON G ALDERSON D GRACE RH MANSI JL YOSEF HMA NORDLE O LAURI H WAHLBY S
Citation: Je. Smyth et al., 2 PHASE-III TRIALS OF TAUROMUSTINE (TCNU) IN ADVANCED COLORECTAL-CANCER, Annals of oncology, 6(9), 1995, pp. 948-949

Authors: SUTEDJA G SCHRAMEL F POSTMUS PE
Citation: G. Sutedja et al., BRONCHOSCOPIC TREATMENT MODALITIES IN LUNG-CANCER, INDICATIONS AND LIMITATIONS, Annals of oncology, 6(9), 1995, pp. 951-952

Authors: BAAS P
Citation: P. Baas, BRONCHOSCOPIC TREATMENT MODALITIES IN LUNG-CANCER, INDICATIONS AND LIMITATIONS - REPLY, Annals of oncology, 6(9), 1995, pp. 952-952
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>